Modified Guishenwan Alleviates Inflammation in Rat Model of Polycystic Ovary Syndrome by Inhibiting MAPK/NF-κB Pathway
|更新时间:2025-01-24
|
Modified Guishenwan Alleviates Inflammation in Rat Model of Polycystic Ovary Syndrome by Inhibiting MAPK/NF-κB Pathway
“The latest research has found that the modified Guishen Pill effectively improves ovarian function and has anti-inflammatory effects in polycystic ovary syndrome rats by inhibiting the MAPK/NF - κ B pathway.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 31, Issue 5, Pages: 86-94(2025)
TIAN Jiayu,QIN Wenyi,YANG Juan,et al.Modified Guishenwan Alleviates Inflammation in Rat Model of Polycystic Ovary Syndrome by Inhibiting MAPK/NF-κB Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(05):86-94.
TIAN Jiayu,QIN Wenyi,YANG Juan,et al.Modified Guishenwan Alleviates Inflammation in Rat Model of Polycystic Ovary Syndrome by Inhibiting MAPK/NF-κB Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(05):86-94. DOI: 10.13422/j.cnki.syfjx.20241842.
Modified Guishenwan Alleviates Inflammation in Rat Model of Polycystic Ovary Syndrome by Inhibiting MAPK/NF-κB Pathway